{
    "clinical_study": {
        "@rank": "121132", 
        "arm_group": [
            {
                "arm_group_label": "Quetiapine", 
                "arm_group_type": "Experimental", 
                "description": "A randomized group will receive quetiapine as treatment for delirium."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "A randomized group will receive placebo, and not quetiapine."
            }
        ], 
        "brief_summary": {
            "textblock": "Many children in the ICU become confused, due to their underlying illness or treatment\n      effects. The medical term for this confusion is delirium. In adults, a medication called\n      quetiapine has been effective in treating delirium. This is considered an \"off label\" use as\n      the FDA has not approved quetiapine for this indication.\n\n      Pediatricians have been using quetiapine to treat delirium in children as well, but there is\n      currently no data proving that it is effective in children. This study is being done to\n      determine if quetiapine is effective for the treatment of ICU delirium in children."
        }, 
        "brief_title": "Efficacy of Quetiapine for Pediatric Delirium", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Delirium", 
        "condition_browse": {
            "mesh_term": "Delirium"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - Any patient in the PICU aged 1 year to 21 years old who is diagnosed with delirium\n\n        Exclusion Criteria:\n\n          -  Age <1\n\n          -  Richmond Agitation Sedation Scale (RASS) score of -4 or -5 (deeply sedated or\n             unarousable).\n\n          -  current treatment for alcohol withdrawal\n\n          -  hepatic encephalopathy\n\n          -  pregnancy\n\n          -  diagnosis of major depressive disorder or bipolar disorder\n\n          -  diagnosis of movement disorder\n\n          -  diagnosis of diabetic ketoacidosis\n\n          -  baseline QTc >500 milliseconds\n\n          -  non-English speaking subjects and/or parent/guardian"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "22 Years", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 4, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02056171", 
            "org_study_id": "1309014323"
        }, 
        "intervention": [
            {
                "arm_group_label": "Quetiapine", 
                "intervention_name": "quetiapine", 
                "intervention_type": "Drug", 
                "other_name": "Seroquil"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Quetiapine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "delirium", 
            "pediatrics", 
            "critical care", 
            "quetiapine"
        ], 
        "lastchanged_date": "March 6, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10065"
                }, 
                "name": "NY Prebyterian Hospital/Weill Cornell Medical Center"
            }, 
            "investigator": [
                {
                    "last_name": "Chani Traube, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Gabrielle Silver, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Robert Witcher, PharmD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Elena Mendez-Rico, PharmD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Christine Joyce, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Efficacy of Quetiapine for Pediatric Delirium", 
        "other_outcome": {
            "measure": "Change in delirium severity", 
            "safety_issue": "No", 
            "time_frame": "within 10 days of study enrollment"
        }, 
        "overall_contact": {
            "email": "chr9008@med.cornell.edu", 
            "last_name": "Chani Traube, MD", 
            "phone": "212-746-3056"
        }, 
        "overall_official": {
            "affiliation": "Weill Medical College of Cornell University", 
            "last_name": "Chani Traube, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Data and Safety Monitoring Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Time to first resolution of delirium", 
            "safety_issue": "No", 
            "time_frame": "Within the first 10 days after study enrollment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02056171"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Total ICU days with delirium", 
            "safety_issue": "No", 
            "time_frame": "Within 30 days after study enrollment"
        }, 
        "source": "Weill Medical College of Cornell University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Weill Medical College of Cornell University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}